Acquisition...15 Jan 2009 09:55
What is interesting in this acquisition is that AVCT will issue shares above the prevailing price, fully underwritten, to the tune of 3p per 67.57Mns shares to be issued as the consideration to pay for the £2.05Mns maximum purchase of Theragenetics Ltd, £23,000 will be in cash. Full details released today. New shares will begin trading on 21st January.